Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Jul 31;9(4):00158-2023.
doi: 10.1183/23120541.00158-2023. eCollection 2023 Jul.

Healthcare costs and resource utilisation in bronchiectasis, asthma and COPD

Raffaella Ronco  1   2 , Giovanni Franco  3 , Matteo Monzio Compagnoni  1   2 , Stefano Aliberti  4   5 , Fabrizio Luppi  3 , Giovani Corrao  1   2 , Paola Faverio  3
Affiliations

Healthcare costs and resource utilisation in bronchiectasis, asthma and COPD

Raffaella Ronco et al. ERJ Open Res. .

Abstract

Direct healthcare costs for patients with asthma are less than half (-52%) and for patients with COPD are 41% higher if compared to those of patients with bronchiectasis. The leading expense items in bronchiectasis are hospitalisations and antibiotics. https://bit.ly/3Iq8AUP.

PubMed Disclaimer

Conflict of interest statement

Conflict of interest: G. Corrao received research support from the European Community, the Italian Medicines Agency (AIFA), and the Italian Ministry of Education, Universities and Research. He took part in a variety of projects that were funded by pharmaceutical companies (Novartis, GSK, Roche, AMGEN and BMS). He also received honoraria as a member of the Advisory Board of Roche. S. Aliberti received consulting fees, honoraria for lectures, presentations or educational events and participation on a data safety monitoring board or advisory board from Insmed, Zambon, AstraZeneca, CLS Behring, Grifols, Fondazione Internazionale Menarini, MSD, Brahms, Physioassist SAS, GlaxoSmithKline Spa and Thermofisher Scientific. He also received royalties from McGraw-Hill. No other potential conflicts of interest were declared for the other authors.

References

    1. Aliberti S, Goeminne PC, O'Donnell AE, et al. . Criteria and definitions for the radiological and clinical diagnosis of bronchiectasis in adults for use in clinical trials: international consensus recommendations. Lancet Respir Med 2022; 10: 298–306. doi:10.1016/S2213-2600(21)00277-0 - DOI - PubMed
    1. Aliberti S, Sotgiu G, Lapi F, et al. . Prevalence and incidence of bronchiectasis in Italy. BMC Pulm Med 2020; 20: 15. doi:10.1186/s12890-020-1050-0 - DOI - PMC - PubMed
    1. Athanazio RA. Bronchiectasis: moving from an orphan disease to an unpleasant socioeconomic burden. ERJ Open Res 2021; 7: 00507-2021. doi: 10.1183/23120541.00507-2021 - DOI - PMC - PubMed
    1. Guan W-J, Han X-R, de la Rosa-Carrillo D, et al. . The significant global economic burden of bronchiectasis: a pending matter. Eur Respir J 2019; 53: 1802392. doi: 10.1183/13993003.02392-2018 - DOI - PubMed
    1. Faverio P, Ronco R, Monzio Compagnoni M, et al. . Effectiveness and economic impact of Dupilumab in asthma: a population-based cohort study. Respir Res 2023; 24: 70. doi: 10.1186/s12931-023-02372-y - DOI - PMC - PubMed

LinkOut - more resources